To explore the peripheral blood markers of diagnosis and curative effect evaluation in mental disorder: an observational study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900028057

Enrollment

Unknown

Registered

2019-12-09

Start date

2019-12-10

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

schizophrenia

Interventions

Gold Standard:Clinical outcomes

Index test:exosomes circRNA

Eligibility

Sex/Gender

All

Age

14 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Aged 14-65 years; (2) graduate from primary school and above; (3) meet the diagnostic criteria of DSM-5 schizophrenia; (4) voluntary participation, and sign by the legal guardian informed consent.

Exclusion criteria

Exclusion criteria: (1) take any antipsychotics for the first 3 months of the group, and have negative life events for the first 6 months of the group; (2) comorbidity of other severe mental disorders, such as depression disorder, bipolar disorder, substance use disorder.

Design outcomes

Primary

Measure	Time frame
exosomes circRNA;SPE, SEN, ACC, AUC of ROC;	—

Secondary

Measure	Time frame
symptoms;	—

Countries

China

Contacts

Public ContactLiu Zhonglin

Sun Yat-sen Memorial Hospital, Sun Yat-sen University

zhonglinliu@126.com+86 13719438236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026